ClinicalTrials.gov
ClinicalTrials.gov Menu

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01647360
Recruitment Status : Completed
First Posted : July 23, 2012
Last Update Posted : May 29, 2013
Sponsor:
Information provided by (Responsible Party):
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2013
  Actual Study Completion Date : May 2013